Peginterferon alfa-2a 180 mcg in 1 mL Injection
RxNorm 351270
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 351270 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: peginterferon alfa-2a 180 mcg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
1 mL peginterferon alfa-2a 0.18 mg/ML Injection
(Atom ID: 7241069)
Designated preferred name (PT):
Interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/mL solution for injection
(Atom ID: 12756111)
Prescribable Name (PSN):
Peginterferon alfa-2a 180 mcg in 1 mL Injection
(Atom ID: 7244827)
Synonym (SY):
Peginterferon alfa-2a 180 mcg/ML Injectable Solution
(Atom ID: 3293573)
Full form of descriptor (FN):
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/1 mL conventional release solution for injection (clinical drug)
(Atom ID: 12757280)
Patient Education
Peginterferon Alfa-2a Injection
Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginterferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2a may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2a may not prevent the spread of hepatitis C or hepatitis B to other people.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
